Text Size

Vitamin D Zinc Fever

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2010 by Assaf-Harofeh Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Assaf-Harofeh Medical Center
ClinicalTrials.gov Identifier:
NCT01080950
First received: March 3, 2010
Last updated: March 4, 2010
Last verified: March 2010
History of Changes
  Purpose

Zinc and vitamin d deficiency are associated with a state of inflammation/atherosclerosis.

There are studies demonstrating an association between vitamin d deficiency and respiratory illnesses.

Both zinc and vitamin d are associated with oxidative stress and inflammation.


Condition
Sepsis
Fever
Vitamin D

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Vitamin d and Zinc Levels in Patients With Fever

Resource links provided by NLM:

Drug Information available for: Vitamin D
U.S. FDA Resources

Further study details as provided by Assaf-Harofeh Medical Center:

Biospecimen Retention:   Samples Without DNA

blood drawn for vitamin d will be freezed and stored until all samples have been collected and only than will it be analyzed.


Estimated Enrollment: 200
Study Start Date: March 2010
Estimated Study Completion Date: March 2011
Estimated Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
fever zinc vit. d
patients with fever but without sepsis
sepsis zinc vit. d
patients with sepsis

Detailed Description:

Both vit. d and zinc share anti inflammatory and anti oxidative actions. vit. d deficiency is associated with an increase in serum levels of proinflammatory cytokines and decreased levels of anti inflammatory cytokines.

there are reports concerning the association of vit. d deficiency with infections.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

patients hospitalized with fever and or sepsis.

Criteria

Inclusion Criteria:

  • age>18 years

Exclusion Criteria:

  • CCT<90
  • taking calcium
  • hyper/hypoparathyroidism
  • active malignancy.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01080950

Contacts
Contact: renana shor, md 97289779240 renanashor@yahoo.com

Locations
Israel
Assaf Harofeh Mc Not yet recruiting
Zerifin, Israel
Principal Investigator: renana shor, md            
Sponsors and Collaborators
Assaf-Harofeh Medical Center
  More Information

No publications provided

Responsible Party: renana shor md, Assaf - Harofeh MC
ClinicalTrials.gov Identifier: NCT01080950     History of Changes
Other Study ID Numbers: vitamin d zinc and fever
Study First Received: March 3, 2010
Last Updated: March 4, 2010
Health Authority: Israel: Ministry of Health

Keywords provided by Assaf-Harofeh Medical Center:
zinc
sepsis
fever
vitamin d

Additional relevant MeSH terms:
Fever
Sepsis
Body Temperature Changes
Signs and Symptoms
Infection
Systemic Inflammatory Response Syndrome
Inflammation
Pathologic Processes
Vitamin D
 Ergocalciferols
Vitamins
Zinc
Bone Density Conservation Agents
Physiological Effects of Drugs
Pharmacologic Actions
Micronutrients
Growth Substances
Trace Elements

ClinicalTrials.gov processed this record on June 18, 2013